Cytochrome P450 sex differences in minipigs and conventional pigs

Pharmacology and Toxicology

Volumn 85, Issue 6, 1999, Pages 174-180

  Skaanild, Mette T ^a   Friis, Christian ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 ISOENZYME; MESSENGER RNA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; IMMUNOCHEMISTRY; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; SWINE; TRANSCRIPTION REGULATION;

EID: 0032825471     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1999.tb00088.x     Document Type: Article

References (19)

1. Chauret, N., A. Gauthier, J. Martin & D. A. Nicoll-Griffth: In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse. Drug Metab. Disp. 1997, 25, 1130-1136.
2. Fujimori, K. A., H. Takahashi, B. S. Numata & A. Takanaka: Drug metabolizing enzyme systems of Göttingen miniature pigs. In: Swine in Biomedical Research 1986, 1, 533-548. Ed.: M. E. Tumbleson. Plenum Press, New York.
3. Guengerich, F. P., M. V. Martin, P. H. Beaune, P. Kremers, T. Wolff & J. Waxman: Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphisme in oxidative drug metabolism. J. Biol. Chem. 1996, 261, 5051-5060.
4. Hakkola, J., M. Pasanen, J. Hukkanen, O. Pelkonen, J. Maenpaa, J. Edwards, A. R. Boobis & H. Raunio: Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta. Biochem. Pharmacol. 1996, 51, 403-411.
5. Hellmold, H., J. G. Lamb, A. Wyss, J. Å. Gustafsson & M. Wqarner: Developmental and endocrine regulation of P450 isoforms in rat breast. Mol. Pharm. 1995, 48, 630-638.
6. Ikeya, K., A. K. Jaiswai, R. A. Owens, J. E. Jones, D. W. Nebert & S. Kimura: Human CYPIA2: Sequence, gene structure, comparison with mouse and rat orthologous gene, and differences in liver IA2 mRNA expression. Mol. Endocrinol. 1989, 3, 1399-1408.
7. th ISMDO meeting 1998.
8. Monshouwer, M., R. F. Witkamp, S. M. Nijmeijer, L. A. M. G. Van Leengoed, H. C. M. Vernooy, J. H. M. Verheijden & A. S. J. R. A. M. Van Miert: A liposaccharide-induced acute phase response in pigs is associated with a decrease in hepatic cytochrome P450-mediated drug metabolism. J. Vet. Pharmacol. Therap. 1996, 19, 382-388.
9. Olsen, A. K., K. T. Hansen & C. Friis: Pig hepatocytes as an in vitro model to study the regulation of human CYP3A4: prediction of drug-drug interactions with 17 alfa-ethynylestradiol. Chemical. Biol. Interact. 1997, 107, 93-108.
10. Omura, T. & R. Sato: The carbon monoxide-binding pigment of liver microsomes, II. Solubilization, purification and properties. J. Biol. Chem. 1964, 239, 2379-2385.
11. Pearce, R. E., C. J. McIntyre, A. Madan, U. Sanzgire, A. J. Draper, P. L. Bullock, D. C. Cook, L. A. Burton, J. Lathan, C. Nevins & A. Parkinson: Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity. Arch. Biochem. Biophys. 1996, 331, 145-169.
12. Persson, I., I. Johansson, H. Bergling, M.-L. Dahl, J. Seidegård, R. Rylander, A. Rannug, J. Högberg & M. I. Sundberg: Genetic polymorphism of cytochrome P4502E1 in a Swedish population. FEBS 1977, 319, 207-211.
13. Peterson, G. L.: A simplification of the protein assay method of Lowry et al., which is more generally applicable. Anal. Biochem. 1977, 83, 346-356.
14. Rutten, A. A., H. E. Falke, J. F. Catsberg, H. M. Wertelboer, B. J. Blaauboer, L. Doorn, F. X. van-Leeuwen, R. Theelen & I. M. Rietjens:Interlaboratory comparison of microsomal ethoxyresorufin and pentoxyresorufin O-dealkylation determinations: standardisation of assay conditions. Arch. Toxicol. 1992, 66, 237-244.
15. Shen, Z., R. L. Wells, J. Liu & M. M. Elkind: Identification of a cytochrome P450 gene by reverse transcription-PCR using degenerate primers containing inosine. Proc. Natl. Acad. 1993, 90, 11483-11487.
16. Shimada, T., H. Yamazaki, M. Mimura, Y. Inui & P. Guengerich: Interindividuel variations in human liver cytochrome P-450 enzyme involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with microsomes of 30 Japanese and 30 Caucasians. J. Pharm. Exp. Therap. 1994, 270, 414-423.
17. Skaanild, M. T. & C. Friis: Characterization of the P450 system in Göttingen minipigs. Pharmacology & Toxicology 1997, 80 (suppl.), 28-33.
18. Thomsen, M. K., C. Friis & P. Nielsen: Purification and characterization of hepatic microsomal cytochrome P-450 in phenobarbital- and ß-naphthoflavone-treated pigs. Pharmacology & Toxicology 1991, 69, 381-385.
19. Witkamp, R. F., S. M. Nijmeijer, M. Monshouwer, G. J. M. J. Horbach & A. J. P. A. M. Van Miert: Effect of pre-treatment with cytochrome P450 inducers on hepatic microsomal oxidative biotransformation activities in pigs. 4th European ISSX meeting, Tour, France, 1993 (abstract).